Your session is about to expire
← Back to Search
Stigma Reduction Strategies for HIV Prevention Engagement
N/A
Waitlist Available
Research Sponsored by Bryan Kutner
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
have had anal intercourse with a man in the past year or intend to in the next year
report being assigned male at birth and identifying currently as male
Timeline
Screening 3 weeks
Treatment Varies
Follow Up (1) baseline, pre-intervention, (2) post-intervention 1 week after completion of mhealth component, (3) post-intervention 1 week after completion of the in-person workshop, (4) post-intervention 3 months after completion of all implementation strategies
Awards & highlights
Study Summary
This trial is to find out how to make healthcare workers more comfortable with anal sex so that gay and bisexual men will be more likely to get HIV-related services.
Who is the study for?
This trial is for males assigned at birth, currently identifying as male, living in the U.S., who have had or plan to have anal intercourse with a man within a year. Participants must be 18+, able to read and communicate in English, and interested in HIV-related services.Check my eligibility
What is being tested?
The study is testing strategies to reduce sexual stigma by healthcare workers towards gay and bisexual men. The goal is to improve these men's engagement in HIV prevention services through developing and piloting an intervention for health professionals.See study design
What are the potential side effects?
Since this trial involves educational interventions rather than medical treatments, traditional physical side effects are not expected. However, participants may experience emotional or psychological responses during the process.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have had or plan to have anal intercourse with a man within a year.
Select...
I was assigned male at birth and identify as male.
Select...
I am 18 years old or older.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ post-intervention, 1 week after completion of the mhealth component
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~post-intervention, 1 week after completion of the mhealth component
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Acceptability, appropriateness, and feasibility of the coaching calls and optional email listserv as assessed by the AFAS
Acceptability, appropriateness, and feasibility of the in-person skills development workshop as assessed by the AFAS
Acceptability, appropriateness, and feasibility of the mHealth component as assessed by the AFAS
+4 moreSecondary outcome measures
Changes to comfort discussing anal health and sexuality as assessed by 6 study-specific items
Changes to determinants of implementation behavior as assessed by the DIBQ
Changes to knowledge about anal health and sexuality as assessed by the iASK
+3 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: Pre-post designExperimental Treatment1 Intervention
The pilot intervention will be evaluated using a pre-post design.
Find a Location
Who is running the clinical trial?
Bryan KutnerLead Sponsor
Albert Einstein College of MedicineOTHER
287 Previous Clinical Trials
11,857,020 Total Patients Enrolled
Columbia UniversityOTHER
1,439 Previous Clinical Trials
2,448,631 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You can read and speak in English.I am a man who has sex with men.You live in the United States.I have had or plan to have anal intercourse with a man within a year.I was assigned male at birth and identify as male.I am 18 years old or older.
Research Study Groups:
This trial has the following groups:- Group 1: Pre-post design
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger